西原広史

医学部臨床研究推進センター

ウェブサイトhttps://k-ris.keio.ac.jp/html/100001653_ja.html

出典: Scopus
Pureの文献数とScopusの被引用数に基づいて算出されます

年別の研究成果

Pureに変更を加えた場合、すぐここに表示されます。

フィンガープリント

Hiroshi Nishiharaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

12 類似のプロファイル

ネットワーク

国レベルでの最近の外部協力。点をクリックして確認してください。

4023 被引用数
34 h-index
190 Article
8 Comment/debate
8 Letter
3 Review article

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
Morimoto, H., Hida, Y., Maishi, N., Nishihara, H., Hatanaka, Y., Li, C., Matsuno, Y., Nakamura, T., Hirano, S. & Hida, K., 2021 5, In: Thoracic Cancer. 12, 9, p. 1347-1357 11 p.
研究成果: Article › 査読

Open Access
1 被引用数 (Scopus)
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using ¹²⁵I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
Takagi, H., Zhao, S., Muto, S., Yokouchi, H., Nishihara, H., Harada, T., Yamaguchi, H., Mine, H., Watanabe, M., Ozaki, Y., Inoue, T., Yamaura, T., Fukuhara, M., Okabe, N., Matsumura, Y., Hasegawa, T., Osugi, J., Hoshino, M., Higuchi, M., Shio, Y. & 22 others, Kanno, R., Aoki, M., Tan, C., Shimoyama, S., Yamazaki, S., Kikuchi, H., Sakakibara-Konishi, J., Oizumi, S., Harada, M., Akie, K., Sugaya, F., Fujita, Y., Takamura, K., Kojima, T., Honjo, O., Minami, Y., Nishimura, M., Dosaka-Akita, H., Nakamura, K., Inano, A., Isobe, H. & Suzuki, H., 2021 3, In: Lung Cancer. 153, p. 134-142 9 p.
研究成果: Article › 査読

Open Access
Diffuse-Type Tenosynovial Giant Cell Tumor Arising in the Temporomandibular Joint Extending to the External Auditory Canal: A Case Report and Literature Review
Suzuki, S., Tsuda, H., Bandoh, N., Goto, T., Uemura, A., Aoyama, T., Nishio, A., Makino, S., Yamaguchi, T., Aimono, E., Nishihara, H. & Harabuchi, Y., 2021, (Accepted/In press) In: Ear, Nose and Throat Journal.
研究成果: Article › 査読

Open Access
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Nakamura, K., Aimono, E., Oba, J., Hayashi, H., Tanishima, S., Hayashida, T., Chiyoda, T., Kosaka, T., Hishida, T., Kawakubo, H., Kitago, M., Okabayashi, K., Funakoshi, T., Okita, H., Ikeda, S., Takaishi, H. & Nishihara, H., 2021 4, In: Medical Oncology. 38, 4, 36.
研究成果: Article › 査読

Open Access
First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion
Shojo, K., Kosaka, T., Nakamura, K., Hongo, H., Kobayashi, H., Mikami, S., Nishihara, H. & Oya, M., 2021 5, In: IJU Case Reports. 4, 3, p. 176-179 4 p.
研究成果: Article › 査読

Open Access

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

Diffuse-Type Tenosynovial Giant Cell Tumor Arising in the Temporomandibular Joint Extending to the External Auditory Canal: A Case Report and Literature Review

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using ¹²⁵I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)